Cryptosporidiosis in patients with HIV/AIDS

AIDS

Volumn 25, Issue 5, 2011, Pages 549-560

  O'Connor, Roberta M ^a   Shaffie, Rehaan ^a   Kang, Gagandeep ^b   Ward, Honorine D ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

AIDS; Cryptosporidium; diarrhea; HIV; opportunistic; parasite; review

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; MANNOSE BINDING LECTIN; NITAZOXANIDE; PLACEBO; PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CLINICAL FEATURE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DEVELOPMENTAL STAGE; DRUG MEGADOSE; EPIDEMIC; FOOD CONTAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; IMMUNOSTIMULATION; INFECTION CONTROL; INFECTION RISK; INNATE IMMUNITY; LABORATORY TEST; LIFE CYCLE; MIXED INFECTION; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SEROPREVALENCE; WATER CONTAMINATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CRYPTOSPORIDIOSIS; DIARRHEA; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST;

EID: 79952450596     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283437e88     Document Type: Review

References (152)

1. Tzipori S, Ward H. Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect 2002; 4:1047-1058. (Pubitemid 35015173)
2. Leav BA, Mackay M, Ward HD. Cryptosporidium species: new insights and old challenges. Clin Infect Dis 2003; 36:903-908. (Pubitemid 36403524)
3. Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am 2006; 35:291-314; viii. (Pubitemid 44118668)
4. Dillingham RA, Lima AA, Guerrant RL. Cryptosporidiosis: epidemiology and impact. Microbes Infect 2002; 4:1059-1066. (Pubitemid 35015174)
5. Collinet-Adler S, Ward HD. Cryptosporidiosis: environmental, therapeutic, and preventive challenges. Eur J Clin Microbiol Infect Dis 2010; 29:927-935.
6. Chen XM, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. N Engl J Med 2002; 346:1723-1731. (Pubitemid 34547487)
7. Tzipori S, Widmer G. A hundred-year retrospective on cryptosporidiosis. Trends Parasitol 2008; 24:184-189.
8. Navin TR, Juranek DD. Cryptosporidiosis: clinical, epidemiologic, and parasitologic review. Rev Infect Dis 1984; 6:313-327.
9. Colford JM Jr, Tager IB, Hirozawa AM, Lemp GF, Aragon T, Petersen C. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am J Epidemiol 1996; 144:807-816. (Pubitemid 26374950)
10. Carr A, Marriott D, Field A, Vasak E, Cooper DA. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998; 351:256-261. (Pubitemid 28043951)
11. Foudraine NA, Weverling GJ, van Gool T, Roos MT, de Wolf F, Koopmans PP, et al. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 1998; 12:35-41. (Pubitemid 28021313)
12. Miao YM, Awad-El-Kariem FM, Franzen C, Ellis DS, Muller A, Counihan HM, et al. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25:124-129.
13. Maggi P, Larocca AM, Quarto M, Serio G, Brandonisio O, Angarano G, et al. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2000; 19:213-217. (Pubitemid 30201298)
14. Nannini EC, Okhuysen PC. HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep 2002; 4:392-398.
15. Werneck-Silva AL, Prado IB. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of highly active antiretroviral therapy. J Gastroenterol Hepatol 2009; 24:135-139.
16. Call SA, Heudebert G, Saag M, Wilcox CM. The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3. Am J Gastroenterol 2000; 95:3142-3146.
17. Misra SN, Sengupta D, Satpathy SK. AIDS in India: recent trends in opportunistic infections. Southeast Asian J Trop Med Public Health 1998; 29:373-376. (Pubitemid 128531567)
18. Savioli L, Smith H, Thompson A. Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol 2006; 22:203-208.
19. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15:145-154. (Pubitemid 34052587)
20. Kuhls TL, Mosier DA, Crawford DL, Griffis J. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis 1994; 18:731-735. (Pubitemid 24145905)
21. Leach CT, Koo FC, Kuhls TL, Hilsenbeck SG, Jenson HB. Prevalence of Cryptosporidium parvum infection in children along the Texas-Mexico border and associated risk factors. Am J Trop Med Hyg 2000; 62:656-661. (Pubitemid 32210491)
22. Frost FJ, Muller T, Craun GF, Lockwood WB, Calderon RL. Serological evidence of endemic waterborne cryptosporidium infections. Ann Epidemiol 2002; 12:222-227. (Pubitemid 34414935)
23. Lake IR, Nichols G, Bentham G, Harrison FC, Hunter PR, Kovats SR. Cryptosporidiosis decline after regulation, England and Wales, 1989-2005. Emerg Infect Dis 2007; 13:623-625. (Pubitemid 46525114)
24. Yoder JS, Harral C, Beach MJ. Cryptosporidiosis surveillance: United States, 2006-2008. MMWR Surveill Summ 2010; 59:1-14.
25. Kaushik K, Khurana S, Wanchu A, Malla N. Evaluation of staining techniques, antigen detection and nested PCR for the diagnosis of cryptosporidiosis in HIV seropositive and seronegative patients. Acta Trop 2008; 107:1-7.
26. Jayalakshmi J, Appalaraju B, Mahadevan K. Evaluation of an enzyme-linked immunoassay for the detection of Cryptosporidium antigen in fecal specimens of HIV/AIDS patients. Indian J Pathol Microbiol 2008; 51:137-138. (Pubitemid 351664720)
27. Navin TR, Weber R, Vugia DJ, Rimland D, Roberts JM, Addiss DG, et al. Declining CD4R T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:154-159. (Pubitemid 29063713)
28. Flanigan T, Whalen C, Turner J, Soave R, Toerner J, Havlir D, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med 1992; 116:840-842. (Pubitemid 23034762)
29. Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kraus P, et al. Seasonality and factors associated with cryptosporidiosis among individuals with HIV infection. Epidemiol Infect 1998; 121:197-204. (Pubitemid 28423347)
30. Khalakdina A, Tabnak F, Sun RK, Colford JM Jr. Race/ethnicity and other risk of factors associated with cryptosporidiosis as an initial AIDS-defining condition in California, 1980-99. Epidemiol Infect 2001; 127:535-543. (Pubitemid 34092801)
31. Caputo C, Forbes A, Frost F, Sinclair MI, Kunde TR, Hoy JF, et al. Determinants of antibodies to Cryptosporidium infection among gay and bisexual men with HIV infection. Epidemiol Infect 1999; 122:291-297. (Pubitemid 29216818)
32. Hellard M, Hocking J, Willis J, Dore G, Fairley C. Risk factors leading to Cryptosporidium infection in men who have sex with men. Sex Transm Infect 2003; 79:412-414. (Pubitemid 37330311)
33. Inungu JN, Morse AA, Gordon C. Risk factors, seasonality, and trends of cryptosporidiosis among patients infected with human immunodeficiency virus. Am J Trop Med Hyg 2000; 62:384-387.
34. Rose JB, Huffman DE, Gennaccaro A. Risk and control of waterborne cryptosporidiosis. FEMS Microbiol Rev 2002; 26:113-123. (Pubitemid 34634083)
35. Xiao L, Feng Y. Zoonotic cryptosporidiosis. FEMS Immunol Med Microbiol 2008; 52:309-323. (Pubitemid 351420749)
36. Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food: 10 States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:333-337.
37. Xiao L, Ryan UM. Cryptosporidiosis: an update in molecular epidemiology. Curr Opin Infect Dis 2004; 17:483-490. (Pubitemid 39407380)
38. Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis 1999; 180:1275-1281. (Pubitemid 30070214)
39. Mac Kenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331:161-167. (Pubitemid 24209566)
40. Hoxie NJ, Davis JP, Vergeront JM, Nashold RD, Blair KA. Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am J Public Health 1997; 87:2032-2035. (Pubitemid 28055927)
41. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8:225-230. (Pubitemid 34202453)
42. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol 2007; 63:387-393. (Pubitemid 46426641)
43. Chen XM, LaRusso NF. Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy. Semin Liver Dis 2002; 22:277-289.
44. Mor SM, Tumwine JK, Ndeezi G, Srinivasan MG, Kaddu- Mulindwa DH, Tzipori S, et al. Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis 2010; 50:1373-1374.
45. Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC, et al. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis 1998; 27:536-542. (Pubitemid 28422004)
46. False-positive laboratory tests for Cryptosporidium involving an enzyme-linked immunosorbent assay: United States, November 1997-March 1998. MMWR Morb Mortal Wkly Rep 1999; 48:4-8.
47. Ajjampur SSR, Rajendran P, Banerjee I, Ramani S, Monica B, Sankaran P, et al. Closing the diagnostic gap in diarrhoea in Indian children by the application of molecular techniques. J Med Microbiol 2008; 57:1364-1368.
48. Morgan UM, Pallant L, Dwyer BW, Forbes DA, Rich G, Thompson RC. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol 1998; 36:995-998. (Pubitemid 28146284)
49. Stockdale HD, Spencer JA, Blagburn BL. Prophylaxis and chemotherapy. In: Fayer R, Xiao L, editors. Cryptosporidium and cryptosporidiosis Boca Raton: CRC Press; 2008. pp. 255-279.
50. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005; 40:1173-1180. (Pubitemid 40490245)
51. White AJ. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev Antiinfect Ther 2004; 2:43-49.
52. Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev 2007; CD004932.
53. Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis 2009; 9:195.
54. Rossignol JF. Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 2010; 124:45-53.
55. Mele R, Gomez Morales MA, Tosini F, Pozio E. Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models. Int J Parasitol 2003; 33:757-764. (Pubitemid 36695027)
56. Hommer V, Eichholz J, Petry F. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum. J Antimicrob Chemother 2003; 52:359-364. (Pubitemid 37120712)
57. Sun T, Teichberg S. Protozoal infections in the acquired immunodeficiency syndrome. J Electron Microsc Tech 1988; 8:79-103. (Pubitemid 18046868)
58. Xiao L. Molecular epidemiology of cryptosporidiosis: an update. Exp Parasitol 2010; 124:80-89.
59. Ajjampur SS, Gladstone BP, Selvapandian D, Muliyil JP, Ward H, Kang G. Molecular and spatial epidemiology of cryptosporidiosis in children in a semiurban community in South India. J Clin Microbiol 2007; 45:915-920. (Pubitemid 46427711)
60. Ajjampur SS, Sankaran P, Kang G. Cryptosporidium species in HIV-infected individuals in India: an overview. Natl Med J India 2008; 21:178-184.
61. Muthusamy D, Rao SS, Ramani S, Monica B, Banerjee I, Abraham OC, et al. Multilocus genotyping of Cryptosporidium sp. isolates from human immunodeficiency virus-infected individuals in South India. J Clin Microbiol 2006; 44:632-634. (Pubitemid 43222269)
62. Cama VA, Ross JM, Crawford S, Kawai V, Chavez-Valdez R, Vargas D, et al. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis 2007; 196:684-691. (Pubitemid 47293849)
63. Rao Ajjampur SS, Asirvatham JR, Muthusamy D, Gladstone BP, Abraham OC, Mathai D, et al. Clinical features & risk factors associated with cryptosporidiosis in HIV infected adults in India. Indian J Med Res 2007; 126:553-557. (Pubitemid 351663586)
64. Houpt ER, Bushen OY, Sam NE, Kohli A, Asgharpour A, Ng CT, et al. Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania. Am J Trop Med Hyg 2005; 73:520-522. (Pubitemid 41324254)
65. Theodos CM. Innate and cell-mediated immune responses to Cryptosporidium parvum. Adv Parasitol 1998; 40:87-119. (Pubitemid 30411806)
66. Riggs MW. Recent advances in cryptosporidiosis: the immune response. Microbes Infect 2002; 4:1067-1080. (Pubitemid 35015175)
67. Borad A, Ward H. Human immune responses in cryptosporidiosis. Future Microbiol 2010; 5:507-519.
68. Leav BA, Yoshida M, Rogers K, Cohen S, Godiwala N, Blumberg RS, et al. An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice. Infect Immun 2005; 73:8425-8428. (Pubitemid 41740336)
69. Hayward AR, Chmura K, Cosyns M. Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice. J Infect Dis 2000; 182:1001-1004.
70. Takeuchi D, Jones VC, Kobayashi M, Suzuki F. Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum. Infect Immun 2008; 76:3657-3663.
71. Pollok RC, Farthing MJ, Bajaj-Elliott M, Sanderson IR, McDonald V. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 2001; 120:99-107. (Pubitemid 32061873)
72. White AC, Robinson P, Okhuysen PC, Lewis DE, Shahab I, Lahoti S, et al. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis 2000; 181:701-709. (Pubitemid 30131842)
73. Choudhry N, Korbel DS, Edwards LA, Bajaj-Elliott M, McDonald V. Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection. Cell Microbiol 2009; 11:1354-1364.
74. Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Lahoti S, et al. Expression of IL-15 and IL-4 in IFN-gammaindependent control of experimental human Cryptosporidium parvum infection. Cytokine 2001; 15:39-46. (Pubitemid 32738410)
75. Chen XM, O'Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 2005; 175:7447-7456. (Pubitemid 41713442)
76. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007; 282:28929-28938. (Pubitemid 47610421)
77. Rogers KA, Rogers AB, Leav BA, Sanchez A, Vannier E, Uematsu S, et al. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect Immun 2006; 74:549-556. (Pubitemid 43023110)
78. Wanyiri J, Ward H. Association of mannose-binding lectin deficiency with cryptosporidiosis. Clin Infect Dis 2006; 43:295-296. (Pubitemid 44078899)
79. Kelly P, Jack DL, Naeem A, Mandanda B, Pollok RC, Klein NJ, et al. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology 2000; 119:1236-1242.
80. Kirkpatrick BD, Huston CD, Wagner D, Noel F, Rouzier P, Pape JW, et al. Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. Clin Infect Dis 2006; 43:289-294. (Pubitemid 44078898)
81. Carmolli M, Duggal P, Haque R, Lindow J, Mondal D, Petri WA Jr, et al. Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children. J Infect Dis 2009; 200:1540-1547.
82. Petry F, Jakobi V, Wagner S, Tessema TS, Thiel S, Loos M. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q-and MBL-deficient mice to infection. Mol Immunol 2008; 45:3392-3400.
83. Le Moing V, Bissuel F, Costagliola D, Eid Z, Chapuis F, Molina JM, et al. Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. AIDS 1998; 12:1395-1397. (Pubitemid 28330737)
84. Gomez Morales MA, Ausiello CM, Urbani F, Pozio E. Crude extract and recombinant protein of Cryptosporidium parvum oocysts induce proliferation of human peripheral blood mononuclear cells in vitro. J Infect Dis 1995; 172:211-216.
85. Gomez Morales MA, La Rosa G, Ludovisi A, Onori AM, Pozio E. Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. J Infect Dis 1999; 179:967-973. (Pubitemid 29159343)
86. Gomez Morales MA, Mele R, Ludovisi A, Bruschi F, Tosini F, Rigano R, et al. Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infect Immun 2004; 72:1306-1310. (Pubitemid 38263749)
87. Bonafonte MT, Smith LM, Mead JR. A 23-kDa recombinant antigen of Cryptosporidium parvuminduces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice. Exp Parasitol 2000; 96:32-41.
88. Ehigiator HN, Romagnoli P, Borgelt K, Fernandez M, McNair N, Secor WE, et al. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. Parasite Immunol 2005; 27:17-28. (Pubitemid 40524989)
89. Singh I, Theodos C, Tzipori S. Recombinant proteins of Cryptosporidium parvum induce proliferation of mesenteric lymph node cells in infected mice. Infect Immun 2005; 73:5245-5248. (Pubitemid 41105690)
90. Theodos CM, Sullivan KL, Griffiths JK, Tzipori S. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Infect Immun 1997; 65:4761-4769. (Pubitemid 27463254)
91. Guk SM, Yong TS, Chai JY. Role of murine intestinal intraepithelial lymphocytes and lamina propria lymphocytes against primary and challenge infections with Cryptosporidium parvum. J Parasitol 2003; 89:270-275.
92. McDonald V, Bancroft GJ. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol 1994; 16:315-320. (Pubitemid 24245578)
93. Adjei AA, Jones JT, Enriquez FJ. Differential intra-epithelial lymphocyte phenotypes following Cryptosporidium parvum challenge in susceptible and resistant athymic strains of mice. Parasitol Int 2000; 49:119-129. (Pubitemid 30407339)
94. Cosyns M, Tsirkin S, Jones M, Flavell R, Kikutani H, Hayward AR. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun 1998; 66:603-607. (Pubitemid 28074201)
95. Hayward AR, Cosyns M, Jones M, Ponnuraj EM. Marrowderived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection. Infect Immun 2001; 69:1630-1634. (Pubitemid 32187619)
96. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003; 82:373-384. (Pubitemid 37445041)
97. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131:47-54. (Pubitemid 27498308)
98. You X, Mead JR. Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice. Parasitology 1998; 117 (Pt 6):525-531. (Pubitemid 28552276)
99. Aguirre SA, Perryman LE, Davis WC, McGuire TC. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4Ralpha betaRIFNgammaR and CD4Ralpha betaRIL-4R lymphocytes in gutassociated lymphoid tissue during resolution of infection. J Immunol 1998; 161:1891-1900. (Pubitemid 28387611)
100. McDonald SA, O'Grady JE, Bajaj-Elliott M, Notley CA, Alexander J, Brombacher F, et al. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines. J Infect Dis 2004; 190:1019-1025. (Pubitemid 39120983)
101. Tessema TS, Dauber E, Petry F. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferongamma and interleukin-12- deficient mice to naive recipients. Vaccine 2009; 27:6575-6581.
102. Tessema TS, Schwamb B, Lochner M, Forster I, Jakobi V, Petry F. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection. Immunobiology 2009; 214: 454-466.
103. Jakobi V, Petry F. Humoral immune response in IL-12 and IFNgamma deficient mice after infection with Cryptosporidium parvum. Parasite Immunol 2008; 30:151-161. (Pubitemid 351171238)
104. Ehigiator HN, McNair N, Mead JR. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice. Exp Parasitol 2007; 115:107-113. (Pubitemid 44820048)
105. Lean IS, McDonald SA, Bajaj-Elliott M, Pollok RC, Farthing MJ, McDonald V. Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferonmediated inhibition of Cryptosporidium parvum reproduction. Infect Immun 2003; 71:4580-4585. (Pubitemid 36919924)
106. Chen W, Harp JA, Harmsen AG. Cryptosporidium parvum infection in gene-targeted B cell-deficient mice. J Parasitol 2003; 89:391-393. (Pubitemid 36523236)
107. Chappell CL, Okhuysen PC, Sterling CR, Wang C, Jakubowski W, Dupont HL. Infectivity of Cryptosporidium parvum in healthy adults with preexisting anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg 1999; 60:157-164. (Pubitemid 29066022)
108. Moss DM, Lammie PJ. Proliferative responsiveness of lymphocytes from Cryptosporidium parvum-exposed mice to two separate antigen fractions from oocysts. Am J Trop Med Hyg 1993; 49:393-401. (Pubitemid 23289399)
109. Frost FJ, Roberts M, Kunde TR, Craun G, Tollestrup K, Harter L, et al. How clean must our drinking water be: the importance of protective immunity. J Infect Dis 2005; 191:809-814. (Pubitemid 40271074)
110. Crabb JH. Antibody-based immunotherapy of cryptosporidiosis. Adv Parasitol 1998; 40:121-149. (Pubitemid 30411807)
111. Martin-Gomez S, Alvarez-Sanchez MA, Rojo-Vazquez FA. Oral administration of hyperimmune anti-Cryptosporidium parvum ovine colostral whey confers a high level of protection against cryptosporidiosis in newborn NMRI mice. J Parasitol 2005; 91:674-678. (Pubitemid 40993460)
112. Sagodira S, Buzoni-Gatel D, Iochmann S, Naciri M, Bout D. Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA. Vaccine 1999; 17:2346-2355. (Pubitemid 29268357)
113. Kobayashi C, Yokoyama H, Nguyen SV, Kodama Y, Kimata T, Izeki M. Effect of egg yolk antibody on experimental Cryptosporidium parvum infection in scid mice. Vaccine 2004; 23:232-235. (Pubitemid 39505094)
114. Cama VA, Sterling CR. Hyperimmune hens as a novel source of anti-Cryptosporidium antibodies suitable for passive immune transfer. J Protozool 1991; 38:42S-43S.
115. Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:348-354. (Pubitemid 26404528)
116. Shield J, Melville C, Novelli V, Anderson G, Scheimberg I, Gibb D, et al. Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS. Arch Dis Child 1993; 69:451-453. (Pubitemid 23308186)
117. Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990; 4:581-584.
118. Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 1998; 26:1324-1329. (Pubitemid 28270160)
119. Perryman LE, Kapil SJ, Jones ML, Hunt EL. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. Vaccine 1999; 17:2142-2149. (Pubitemid 29197281)
120. Riggs MW, Schaefer DA, Kapil SJ, Barley-Maloney L, Perryman LE. Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis. Antimicrob Agents Chemother 2002; 46:275-282. (Pubitemid 34087168)
121. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5:783-792. (Pubitemid 41400852)
122. Schmidt W, Wahnschaffe U, Schafer M, Zippel T, Arvand M, Meyerhans A, et al. Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology 2001; 120:984-987. (Pubitemid 32193195)
123. Kaushik K, Khurana S, Wanchu A, Malla N. Lymphoproliferative and cytokine responses to Cryptosporidium parvum in patients coinfected with C. parvum and human immunodeficiency virus. Clin Vaccine Immunol 2009; 16:116-121.
124. Wang HC, Dann SM, Okhuysen PC, Lewis DE, Chappell CL, Adler DG, et al. High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect Immun 2007; 75:481-487. (Pubitemid 46047924)
125. O'Hara SP, Small AJ, Nelson JB, Badley AD, Chen XM, Gores GJ, et al. The human immunodeficiency virus type 1 Tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun 2007; 75:684-696. (Pubitemid 46203430)
126. Yoder JS, Beach MJ. Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol 2010; 124: 31-39.
127. Valderrama AL, Hlavsa MC, Cronquist A, Cosgrove S, Johnston SP, Roberts JM, et al. Multiple risk factors associated with a large statewide increase in cryptosporidiosis. Epidemiol Infect 2009; 1-8.
128. Egorov A, Frost F, Muller T, Naumova E, Tereschenko A, Ford T. Serological evidence of Cryptosporidium infections in a Russian city and evaluation of risk factors for infections. Ann Epidemiol 2004; 14:129-136. (Pubitemid 38221171)
129. Roy SL, DeLong SM, Stenzel SA, Shiferaw B, Roberts JM, Khalakdina A, et al. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. J Clin Microbiol 2004; 42:2944-2951. (Pubitemid 38938041)
130. Boehmer TK, Alden NB, Ghosh TS, Vogt RL. Cryptosporidiosis from a community swimming pool: outbreak investigation and follow-up study. Epidemiol Infect 2009; 1-4.
131. Ethelberg S, Lisby M, Vestergaard LS, Enemark HL, Olsen KE, Stensvold CR, et al. A foodborne outbreak of Cryptosporidium hominis infection. Epidemiol Infect 2009; 137:348-356.
132. Cruz JR, Cano F, Caceres P, Chew F, Pareja G. Infection and diarrhea caused by Cryptosporidium sp. among Guatemalan infants. J Clin Microbiol 1988; 26:88-91. (Pubitemid 18049428)
133. Snel SJ, Baker MG, Venugopal K. The epidemiology of cryptosporidiosis in New Zealand, 1997-2006. N Z Med J 2009; 122:47-61.
134. Gait R, Soutar RH, Hanson M, Fraser C, Chalmers R. Outbreak of cryptosporidiosis among veterinary students. Vet Rec 2008; 162:843-845.
135. McGuigan CC, Steven K, Pollock KG. Cryptosporidiosis associated with wildlife center, Scotland. Emerg Infect Dis 2010; 16:895-896.
136. Cornet M, Romand S, Warszawski J, Bouree P. Factors associated with microsporidial and cryptosporidial diarrhea in HIV infected patients. Parasite 1996; 3:397-401. (Pubitemid 126438013)
137. Blanco MA, Iborra A, Vargas A, Nsie E, Mba L, Fuentes I. Molecular characterization of Cryptosporidium isolates from humans in Equatorial Guinea. Trans R Soc Trop Med Hyg 2009; 103:1282-1284.
138. Zavvar M, Sadraei J, Emadi H, Pirestani M. The use of a nested PCR-RFLP technique, based on the parasite's 18S ribosomal RNA, to characterise Cryptosporidium isolates from HIV/ AIDS patients. Ann Trop Med Parasitol 2008; 102:597-601.
139. Nuchjangreed C, Boonrod K, Ongerth J, Karanis P. Prevalence and molecular characterization of human and bovine Cryptosporidium isolates in Thailand. Parasitol Res 2008; 103: 1347-1353.
140. Araujo AJ, Kanamura HY, Almeida ME, Gomes AH, Pinto TH, Da Silva AJ. Genotypic identification of Cryptosporidium spp. isolated from HIV-infected patients and immunocompetent children of Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 2008; 50:139-143. (Pubitemid 351968853)
141. Gatei W, Barrett D, Lindo JF, Eldemire-Shearer D, Cama V, Xiao L. Unique Cryptosporidium population in HIV-infected persons, Jamaica. Emerg Infect Dis 2008; 14:841-843. (Pubitemid 351838659)
142. Samie A, Bessong PO, Obi CL, Sevilleja JE, Stroup S. Houpt E, et al. Cryptosporidium species: preliminary descriptions of the prevalence and genotype distribution among school children and hospital patients in the Venda region, Limpopo Province, South Africa. Exp Parasitol 2006; 114:314-322. (Pubitemid 44634435)
143. Llorente MT, Clavel A, Goni MP, Varea M, Seral C, Becerril R, et al. Genetic characterization of Cryptosporidium species from humans in Spain. Parasitol Int 2007; 56:201-205. (Pubitemid 46963097)
144. Raccurt CP, Brasseur P, Verdier RI, Li X, Eyma E, Stockman CP, et al. Human cryptosporidiosis and Cryptosporidium spp. in Haiti. Trop Med Int Health 2006; 11:929-934. (Pubitemid 43846453)
145. Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, Ndeezi G, Downing R, Feng X, et al. Cryptosporidiosis and microsporidiosis in ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hyg 2005; 73:921-925. (Pubitemid 41688469)
146. Cama VA, Bern C, Sulaiman IM, Gilman RH, Ticona E, Vivar A, et al. Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J Eukaryot Microbiol 2003; 50 (Suppl):531-533. (Pubitemid 38043007)
147. Gatei W, Greensill J, Ashford RW, Cuevas LE, Parry CM, Cunliffe NA, et al. Molecular analysis of the 18S rRNA gene of Cryptosporidium parasites from patients with or without human immunodeficiency virus infections living in Kenya, Malawi, Brazil, the United Kingdom, and Vietnam. J Clin Microbiol 2003; 41:1458-1462. (Pubitemid 36428089)
148. Gatei W, Ashford RW, Beeching NJ, Kamwati SK, Greensill J, Hart CA. Cryptosporidium muris infection in an HIV-infected adult, Kenya. Emerg Infect Dis 2002; 8:204-206. (Pubitemid 34202446)
149. Leav BA, Mackay MR, Anyanwu A, RM OC, Cevallos AM, Kindra G, et al. Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa. Infect Immun 2002; 70:3881-3890. (Pubitemid 34666029)
150. Tiangtip R, Jongwutiwes S. Molecular analysis of Cryptosporidium species isolated from HIV-infected patients in Thailand. Trop Med Int Health 2002; 7:357-364. (Pubitemid 34595604)
151. Morgan U, Weber R, Xiao L, Sulaiman I, Thompson RC, Ndiritu W, et al. Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virusinfected individuals living in Switzerland, Kenya, and the United States. J Clin Microbiol 2000; 38:1180-1183. (Pubitemid 30140580)
152. Cevallos AM, Zhang X, Waldor MK, Jaison S, Zhou X, Tzipori S, et al. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun 2000; 68:4108-4116. (Pubitemid 30434566)